Suppr超能文献

实验性糖尿病中与山梨醇途径无关的轴突运输缺陷。

Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway.

作者信息

Tomlinson D R, Willars G B, Calthrop-Owen E F

出版信息

Exp Neurol. 1987 Apr;96(1):194-202. doi: 10.1016/0014-4886(87)90180-4.

Abstract

This study examined the effect of experimental diabetes on the anterograde and retrograde axonal transport of phosphofructokinase activity. Rats with streptozotocin-induced diabetes of 4 weeks duration showed phosphofructokinase activity accumulation deficits both proximal (53% and 65% in two separate experiments) and distal (80% and 70%) to 24-h sciatic nerve constrictions. There was no significant effect of diabetes on the phosphofructokinase activity per unit length in unconstricted sciatic nerve. Treatment of a group of diabetic rats with the aldose reductase inhibitor, sorbinil, profoundly reduced the concentrations of polyol pathway metabolites (sorbitol and fructose) in sciatic nerve. This effective inhibition of aldose reductase did not alter the accumulation deficits of phosphofructokinase activity on either side of sciatic nerve constrictions. We conclude that short-term experimental diabetes causes impaired axonal transport of phosphofructokinase activity by mechanisms unrelated to aldose reductase.

摘要

本研究检测了实验性糖尿病对磷酸果糖激酶活性顺行和逆行轴突运输的影响。患有链脲佐菌素诱导的、病程4周糖尿病的大鼠,在坐骨神经24小时缩窄处近端(两个独立实验中分别为53%和65%)和远端(80%和70%)均出现磷酸果糖激酶活性积累缺陷。糖尿病对未缩窄坐骨神经中单位长度的磷酸果糖激酶活性无显著影响。用醛糖还原酶抑制剂索比尼尔治疗一组糖尿病大鼠,可显著降低坐骨神经中多元醇途径代谢产物(山梨醇和果糖)的浓度。醛糖还原酶的这种有效抑制并未改变坐骨神经缩窄两侧磷酸果糖激酶活性的积累缺陷。我们得出结论,短期实验性糖尿病通过与醛糖还原酶无关的机制导致磷酸果糖激酶活性的轴突运输受损。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验